Telemedicine Clinic for Prostate Cancer Patients

Grand River Hospital80 enrolled

Overview

This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferencing as a platform for patients with prostate cancer receiving oral chemotherapy agents.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Cancer, Treatment-Related

Interventions

Visits conducted via TelemedicineOTHER

Patients will be followed via telemedicine with visits lead by a Pharmacist and a Nurse

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Male over 18 years of age with prostate cancer receiving oral treatment with abiraterone or enzalutamide. 2. Ability to provide consent to study. 3. Willingness to complete study questionnaires and a semi-structured exit interview. 4. Adequate command of the English language to complete study questionnaire and survey. 5. Access to technology to allow a link to the virtual telemedicine clinic. (excluding control group) 6. Willingness to participate in videoconference with pharmacist or nurse from their home environment. (excluding control group) Exclusion Criteria: 1. Patients receiving oral anti-cancer therapy other than abiraterone and enzalutamide. 2. Patients lacking the technology at home to participate in the virtual telemedicine clinic. (excluding control group) \-

Locations (1)

Grand River Hospital

Kitchener, Ontario, Canada

RECRUITING

Outcomes

Primary Outcomes

Patient satisfaction with overall care

The primary outcome will be a comparison of patient satisfaction with overall care utilizing a validated scale between the group of patients using the OTN clinic and a group of control patients receiving conventional care at GRRCC

Time frame: 2 Years

Central Contacts

Stacey Hubay, MD, FRCPC

CONTACT

519-749-4370 stacey.hubay@grhosp.on.ca

Carla Girolametto, MA, MHSC

CONTACT

519-749-4370 carla.girolametto@grhosp.on.ca

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.